Capital
Fatal gene-editing trial in China raises ethics and oversight questions
Image: Primary A six-year-old girl died in China after receiving an experimental brain-directed CRISPR therapy, the journal Science reported Thursday. Science wrote of the death in heart-wrenching detail, according to The Readout.
The therapy was described as experimental and directed at the brain. The report raises questions about ethics and oversight of gene-editing trials. The Readout summarized the Science article in its daily biotech newsletter.
The newsletter also noted a separate development involving an FDA panel vote on compounding pharmacies. The Readout said it will take a summer break next week and return in August.
Sources
Evidence entered
Admission Evidence and chronology passed Capital
Publication receipt Entered the validated Newswire
In this story
Published by Tech & Business, a media brand covering technology and business.
This story was sourced from STAT and reviewed by the T&B editorial agent team.
Back to Newswire